Description and clinical application of the Pulfrich effect
Citation Manager Formats
Make Comment
See Comments

This article requires a subscription to view the full text. If you have a subscription you may use the login form below to view the article. Access to this article can also be purchased.
Abstract
Background: In 1922, German physicist Carl Pulfrich described an illusory binocular perceptual disturbance in which an object moving across an observer's field of vision is perceived as traveling along a curved trajectory.
Objective: To review the discovery of the Pulfrich effect, and subsequent clinical applications.
Methods: We translated Pulfrich's description and searched for subsequent publications using electronic databases and review of reference lists in identified publications.
Results: In 1901, Pulfrich developed an optical device to accurately compare stereoscopic photographs, but brightness difference between plates caused distance misperceptions that interfered with precise measurements. Pulfrich proposed that this Stereo-Effekt resulted from interocular differences in perceptual latency. He induced the effect by placing a smoked glass in front of one eye. The resulting perceptual disparity creates an apparently curved trajectory of an object moving sideways across the field of vision. Pulfrich also recognized that visual pathway disorders can produce a pathologic Stereo-Effekt. In 1925, Grimsdale demonstrated this in a man with unilateral retrobulbar optic neuritis and suggested treatment with a neutral density filter (NDF) over the good eye. Not until the 1970s, however, was the Pulfrich effect evaluated as a diagnostic test for retrobulbar optic neuritis and the therapeutic efficacy of an NDF confirmed.
Conclusion: Although the clinical importance of the Pulfrich effect was suggested by Pulfrich and quickly confirmed, it took decades before its diagnostic utility and the efficacy of an NDF were assessed. Recognition remains clinically important to minimize safety risks and mislabeling, and because resulting misperceptions can be easily treated.
GLOSSARY
- NDF=
- neutral density filter
Footnotes
Presented in part at the 66th annual meeting of the American Academy of Neurology, Philadelphia, PA, on April 28, 2014.
Go to Neurology.org for full disclosures. Funding information and disclosures deemed relevant by the authors, if any, are provided at the end of the article.
Supplemental data at Neurology.org
- Received November 9, 2014.
- Accepted in final form February 24, 2015.
- © 2015 American Academy of Neurology
AAN Members
We have changed the login procedure to improve access between AAN.com and the Neurology journals. If you are experiencing issues, please log out of AAN.com and clear history and cookies. (For instructions by browser, please click the instruction pages below). After clearing, choose preferred Journal and select login for AAN Members. You will be redirected to a login page where you can log in with your AAN ID number and password. When you are returned to the Journal, your name should appear at the top right of the page.
AAN Non-Member Subscribers
Purchase access
For assistance, please contact:
AAN Members (800) 879-1960 or (612) 928-6000 (International)
Non-AAN Member subscribers (800) 638-3030 or (301) 223-2300 option 3, select 1 (international)
Sign Up
Information on how to subscribe to Neurology and Neurology: Clinical Practice can be found here
Purchase
Individual access to articles is available through the Add to Cart option on the article page. Access for 1 day (from the computer you are currently using) is US$ 39.00. Pay-per-view content is for the use of the payee only, and content may not be further distributed by print or electronic means. The payee may view, download, and/or print the article for his/her personal, scholarly, research, and educational use. Distributing copies (electronic or otherwise) of the article is not allowed.
Letters: Rapid online correspondence
- Pulfrich Effect: Reply to Dr. Sternman
- Douglas J. Lanska, Physician, VA Medical Center, Tomah, WIdouglas.lanska@gmail.com
- James M. Lanska, Tomah, WI; Bernd F. Remler, Milwaukee, WI
Submitted July 08, 2015 - That's truly eye grabbing
- David Sternman, Neurologist, St. Luke's Roosevelt Hospital, NYCdavidsternman@yahoo.com
Submitted July 07, 2015
REQUIREMENTS
You must ensure that your Disclosures have been updated within the previous six months. Please go to our Submission Site to add or update your Disclosure information.
Your co-authors must send a completed Publishing Agreement Form to Neurology Staff (not necessary for the lead/corresponding author as the form below will suffice) before you upload your comment.
If you are responding to a comment that was written about an article you originally authored:
You (and co-authors) do not need to fill out forms or check disclosures as author forms are still valid
and apply to letter.
Submission specifications:
- Submissions must be < 200 words with < 5 references. Reference 1 must be the article on which you are commenting.
- Submissions should not have more than 5 authors. (Exception: original author replies can include all original authors of the article)
- Submit only on articles published within 6 months of issue date.
- Do not be redundant. Read any comments already posted on the article prior to submission.
- Submitted comments are subject to editing and editor review prior to posting.
You May Also be Interested in
Dr. Ann Yeh and Dr. Daniela Castillo Villagrán
► Watch
Topics Discussed
Alert Me
Recommended articles
-
Drugs and Devices
The application of optical coherence tomography in neurologic diseasesRamiro S. Maldonado, Pradeep Mettu, Mays El-Dairi et al.Neurology: Clinical Practice, September 17, 2015 -
Articles
Diagnostic accuracy of retinal abnormalities in predicting disease activity in MSJorge Sepulcre, Manuel Murie-Fernandez, Angel Salinas-Alaman et al.Neurology, April 30, 2007 -
Article
Optical coherence tomography is highly sensitive in detecting prior optic neuritisSarah Chaoying Xu, Randy H. Kardon, Jacqueline A. Leavitt et al.Neurology, January 23, 2019 -
Articles
Optical coherence tomography and disease subtype in multiple sclerosisM. Pulicken, E. Gordon-Lipkin, L. J. Balcer et al.Neurology, November 26, 2007


